Respiratory · Critical Care

ARDS

Non-cardiogenic pulmonary edema, diffuse alveolar damage, and the vent settings that save lives.

Opening Challenge

A 52-year-old man with severe pancreatitis develops worsening hypoxemia over 24 hours. ABG shows PaO2 of 55 mmHg on FiO2 of 0.8, giving a P/F ratio of 69. Chest X-ray shows bilateral infiltrates. PCWP is 12 mmHg. Echocardiogram shows normal LV function and no wall motion abnormalities. According to the Berlin criteria, what severity of ARDS does this patient have?

A) Mild ARDS (P/F ratio 200-300)
B) Moderate ARDS (P/F ratio 100-200)
C) Severe ARDS (P/F ratio <100)
D) Cardiogenic pulmonary edema, not ARDS
Severe ARDS. Berlin criteria classify ARDS severity by P/F ratio: Mild = 200-300, Moderate = 100-200, Severe = <100. PaO2 55 / FiO2 0.8 = P/F of 69, which falls squarely in the severe category. The PCWP of 12 mmHg (<18) and normal echo rule out cardiogenic pulmonary edema as the primary cause. All four Berlin criteria are met: onset within 1 week, bilateral infiltrates, non-cardiogenic origin, and P/F <100 on at least PEEP 5.
01 · Mechanism

Pathophysiology

From insult to flooded alveoli. What breaks, and why it matters for treatment.

Direct Causes · Pulmonary

Lung Insults

Direct injury to the alveolar-capillary interface from within the lung itself.

Pneumonia is the #1 direct cause overall. Aspiration of gastric contents, pulmonary contusion (trauma), inhalation injury (smoke, chemical), and near-drowning round out the list.

Pneumonia #1 Aspiration Pulmonary contusion Inhalation injury Near-drowning

Indirect Causes · Extrapulmonary

Systemic Insults

Systemic inflammatory response damages the alveolar-capillary membrane from the vascular side.

Sepsis is the #1 cause of ARDS overall (including indirect). Pancreatitis, massive transfusion (TRALI), burns, trauma/shock, and drug overdose (heroin, salicylates) are classic indirect causes.

Sepsis #1 overall Pancreatitis Massive transfusion (TRALI) Burns Drug OD
Diffuse Alveolar Damage (DAD) is the histological hallmark of ARDS. It unfolds in three phases. The key: each phase has distinct findings and the fibrotic phase is why some patients never fully recover.

Phase 1 · Days 1-7

Exudative Phase

Neutrophils flood the alveoli, driven by cytokine storm (IL-1, IL-6, TNF). They release proteases and reactive oxygen species that destroy the alveolar-capillary barrier. Capillary leak allows protein-rich fluid to pour into alveolar spaces. Fibrin and cellular debris form hyaline membranes (the pathognomonic histologic finding). Type I pneumocytes die. Surfactant is inactivated by the proteinaceous fluid.

Neutrophil influx Cytokine storm Hyaline membranes Protein-rich exudate Surfactant inactivation

Phase 2 · Days 7-21

Proliferative Phase

Type II pneumocytes (the stem cells of the alveolar epithelium) proliferate to replace destroyed type I cells and to restore surfactant production. Inflammatory infiltrate begins to resolve. Some patients recover here. Others progress to the fibrotic phase.

Type II pneumocyte proliferation Repair attempt Potential recovery point

Phase 3 · >21 Days

Fibrotic Phase

Fibroblasts invade the injured tissue. The lung stiffens dramatically as scar tissue replaces functional parenchyma. Compliance falls further. Patients who enter this phase have prolonged ventilator dependence and may develop pulmonary hypertension. Some patients have long-term lung impairment.

Fibroblast invasion Reduced compliance Pulmonary hypertension risk Long-term impairment
Alveolar flooding → Surfactant inactivation → Low compliance (stiff lungs) → Need high pressures to ventilate

Gas Exchange Problem

Shunt Physiology

Flooded alveoli are perfused but not ventilated (true shunt). Blood passes through these segments without picking up oxygen. This is why ARDS hypoxemia is refractory: giving more O2 can't help alveoli that are filled with fluid and completely non-ventilated. You can't oxygenate what isn't being ventilated.

True intrapulmonary shunt O2 therapy alone fails Ventilation is the fix

V/Q Mismatch

Dead Space

Some alveoli are ventilated but not perfused (dead space), due to microthrombi and vasoconstriction. This wasted ventilation means CO2 cannot be excreted efficiently. As dead space increases and respiratory muscles fatigue, hypercapnia develops on top of the hypoxemia.

Dead space ventilation CO2 retention Respiratory muscle fatigue

Mechanical Problem

Low Compliance

Fluid-filled, surfactant-depleted lungs are stiff. Low compliance means normal tidal volumes require much higher airway pressures. This creates a catch-22: you need pressure to ventilate, but pressure causes ventilator-induced lung injury. The solution is lung-protective ventilation.

Stiff lungs High plateau pressures VILI risk
ARDS refractory hypoxemia = shunt physiology. Supplemental O2 alone cannot fix flooded alveoli. Ventilation (PEEP, prone positioning) physically recruits alveoli and restores ventilation to perfused units. This is why ARDS requires mechanical ventilation, not just a non-rebreather mask.
02 · Diagnosis

Berlin Criteria

Four criteria. All required. Severity drives management.

Mild
200-300
PEEP ≥5 cmH2O
Moderate
100-200
PEEP ≥5 cmH2O
Severe
<100
PEEP ≥5 cmH2O
P/F ratio = PaO2 (mmHg) / FiO2 (decimal). Normal lung: P/F ~500. On room air (FiO2 0.21), normal PaO2 is ~100 mmHg, so 100/0.21 = 476. Below 300 = ARDS territory. Below 100 = severe, often needs rescue therapy (prone, ECMO).
1
Timing: acute onset within 1 week of a known clinical insult OR new/worsening respiratory symptoms within 1 week.
2
Imaging: bilateral opacities on CXR or CT that are NOT fully explained by effusions, lobar/lung collapse, or nodules.
3
Origin of edema: respiratory failure NOT fully explained by cardiac failure or fluid overload. If unclear, objective assessment (e.g., echocardiogram) needed to exclude hydrostatic edema. PCWP <18 mmHg supports non-cardiogenic origin.
4
Oxygenation: P/F ratio as classified above, with minimum PEEP ≥5 cmH2O (on mechanical ventilation or CPAP). The PEEP requirement is critical: it standardizes the measurement.
ARDS vs cardiogenic pulmonary edema: Both give bilateral infiltrates and hypoxemia. Key differentiators: PCWP <18 (ARDS) vs ≥18 (cardiogenic), BNP low vs elevated, echo showing normal LV vs depressed LV, context (sepsis/pancreatitis vs CHF/MI), and the fact that the protein content of the edema fluid is HIGH in ARDS (from capillary leak) vs LOW in cardiogenic (hydrostatic).
03 · Mechanical Ventilation

Lung Protective Ventilation

The ARDSNET protocol changed ARDS mortality. The three pillars every exam tests.

Low Tidal Volume · ARDSNET Protocol ▼
Target tidal volume: 6 mL/kg of ideal body weight (IBW), not actual body weight. IBW is calculated from height. A 5 ft 10 in man has an IBW of ~75 kg regardless of actual weight, so TV = 6 x 75 = 450 mL.

Target plateau pressure <30 cmH2O. Plateau pressure reflects alveolar pressure at end-inspiration, the best surrogate for overdistension.

Why this works: high tidal volumes overdistend the remaining open alveoli (volutrauma), cause barotrauma, and trigger cyclic recruitment-derecruitment (atelectrauma), all of which amplify the inflammatory injury (biotrauma). The ARDSNET landmark trial showed a 22% relative mortality reduction comparing 6 mL/kg vs 12 mL/kg IBW.
6 mL/kg IBW Plateau Pr <30 cmH2O Prevents VILI 22% mortality reduction
PEEP Strategy ▼
Positive End-Expiratory Pressure keeps alveoli open at end-expiration, preventing cyclic collapse (atelectrauma) and improving oxygenation by recruiting collapsed alveolar units.

Start at 5-10 cmH2O, titrate upward based on oxygenation response and hemodynamics. Higher PEEP is generally used in more severe ARDS.

Trade-off to know: high PEEP increases intrathoracic pressure, which decreases venous return to the heart and can reduce cardiac output. Watch for hypotension when PEEP is increased, especially in volume-depleted patients. PEEP also risks overdistension of already-open alveoli if set too high.
Prevents atelectrauma Start 5-10 cmH2O High PEEP: decreased CO risk Titrate to oxygenation
Permissive Hypercapnia ▼
To maintain low tidal volumes and low pressures, clinicians accept higher PaCO2, a strategy called permissive hypercapnia. Target: PaCO2 up to 50-60 mmHg, as long as pH stays above 7.20.

Respiratory acidosis from CO2 retention is generally well tolerated by the cardiovascular and renal systems in the short term.

Critical exception: Do NOT use permissive hypercapnia in patients with elevated intracranial pressure (head trauma, stroke). CO2 causes cerebral vasodilation and will worsen cerebral edema. If a patient has ARDS plus a head injury, this creates a dangerous management conflict.
Accept PaCO2 50-60 mmHg pH >7.20 is acceptable No permissive hypercapnia + elevated ICP Preserves low Tv & Pplat
ARDS vent = LOW volume (6 mL/kg IBW) + ADEQUATE PEEP + accept high CO2. High pressures and high volumes kill more patients than permissive hypercapnia does. Every answer that says "increase tidal volume to normalize PaCO2" is wrong in ARDS.
04 · Advanced Management

Rescue Therapies

When standard lung-protective ventilation is not enough. Know what works and what does not.

Prone Positioning ▼
Flipping the patient face-down redistributes perfusion toward the dorsal lung regions, which are typically better-ventilated when prone. This improves V/Q matching across both lungs simultaneously.

Used in severe ARDS (P/F <150). The PROSEVA trial demonstrated a significant mortality benefit when patients were proned for more than 16 hours per day. This is now standard of care for severe ARDS in ICUs with the capability.

Contraindications: unstable spinal injuries, open abdomen wounds, unstable long-bone fractures, and hemodynamic instability that prevents safe repositioning.
PROSEVA trial: mortality benefit P/F <150 threshold >16 hours/day CI: spinal instability
Neuromuscular Blockade ▼
Cisatracurium infusion for the first 48 hours in moderate-to-severe ARDS reduces ventilator dyssynchrony (patient fighting the vent), decreases metabolic oxygen consumption, and may reduce the systemic inflammatory cascade.

The ACURASYS trial suggested mortality benefit. The subsequent ROSE trial did not replicate this with deep sedation as the comparator. Current practice: cisatracurium is used selectively when dyssynchrony is refractory to sedation optimization.
Cisatracurium First 48 hours Reduces dyssynchrony ACURASYS / ROSE trials
ECMO (VV-ECMO) ▼
Veno-venous ECMO removes blood, oxygenates it externally via a gas-exchange membrane, removes CO2, and returns it to the venous circulation. The lung is essentially bypassed entirely.

This is a last resort for truly refractory ARDS unresponsive to all other interventions. The EOLIA trial did not show a statistically significant mortality benefit as a primary endpoint, though a crossover effect and meta-analyses suggest benefit in the most severe cases. VV-ECMO requires specialized centers and carries significant risk.
Last resort Bypasses the lung EOLIA trial Specialized centers only
What Does NOT Work ▼
Inhaled nitric oxide (iNO): Improves oxygenation short-term by vasodilating perfused lung units, but no mortality benefit in any trial. Not a standard therapy.

Surfactant: Works dramatically in neonatal RDS (where the problem is surfactant deficiency). In adult ARDS, the problem is surfactant inactivation by protein-rich exudate, not deficiency. Exogenous surfactant is rapidly inactivated and does not improve outcomes.

Steroids: Controversial. Potentially helpful in the fibroproliferative phase (if not improving by day 7-14, methylprednisolone may slow fibrosis). NOT recommended in early ARDS. Harmful if given late (>14 days of onset in older studies). The LaSRS trial showed harm with late steroids.
iNO: no mortality benefit Surfactant: no benefit in adults Steroids: only fibroproliferative phase Works in neonatal RDS, not ARDS
05 · Elimination Game

Eliminate the Wrong Answers

Use each clue to knock out a choice. The last one standing is correct.

A 60-year-old man with septic shock from a urinary source is intubated on day 2 of his ICU stay. He has bilateral infiltrates, PaO2/FiO2 = 150, and PCWP of 10 mmHg. BNP is 120 pg/mL (normal). He is now on the ventilator. Which tidal volume should be targeted?
12 mL/kg actual body weight
6 mL/kg ideal body weight
10 mL/kg ideal body weight
8 mL/kg actual body weight
Clue 1: The ARDSNET trial compared 6 mL/kg vs 12 mL/kg ideal body weight. The higher tidal volume group had significantly more ventilator-induced lung injury and a 22% higher absolute mortality. High tidal volumes in ARDS kill.
Clue 2: Plateau pressures drive VILI, not tidal volumes per se, but TV is the input. Even 10 mL/kg IBW consistently exceeds the safe plateau pressure threshold (<30 cmH2O) in patients with ARDS-level low compliance.
Clue 3: Tidal volume in ARDS is always calculated using ideal body weight (based on height), not actual body weight. An obese patient's lungs are not proportionally larger. Using actual weight massively overdistends the lung.
6 mL/kg ideal body weight. ARDSNET protocol: 6 mL/kg IBW. Plateau pressure <30 cmH2O. Accept permissive hypercapnia. The other three choices either use the wrong weight basis (actual vs ideal) or the wrong target (10 or 12 mL/kg, which overdistend ARDS lungs).
06 · Retrieval Practice

Quiz

Eight board-style questions. Original vignettes. Pick before reading the explanation.

Question 1 of 8

A 54-year-old woman with ARDS secondary to gram-negative sepsis has been mechanically ventilated for 36 hours. Her PaO2/FiO2 ratio is 130 on FiO2 0.7 and PEEP 12. She has been proned for 18 hours per day for 2 days without improvement.

Which intervention has the strongest evidence for mortality reduction in patients with severe ARDS (P/F <150)?
AInhaled nitric oxide
BProne positioning for >16 hours/day
CEarly high-dose methylprednisolone
DSurfactant replacement therapy
Correct: B

Tempting to pick iNO: it improves oxygenation numbers on the monitor, which looks like winning. The trap is that improving a number is not the same as improving survival. The exam rewards knowing which intervention actually reduces mortality, not which one changes the readout. Prone positioning for severe ARDS (P/F <150) is the rescue therapy with the strongest mortality data. The PROSEVA trial showed a 16% absolute mortality reduction (from 32.8% to 16%) with prone positioning >16 hours/day in severe ARDS. Think of prone positioning as flipping a waterlogged sponge: the dependent zones that were drowning in fluid are now on top and can drain, while the previously collapsed upper zones get perfused. iNO improves oxygenation transiently but has no mortality benefit in any RCT. High-dose steroids early in ARDS are not indicated and some studies show harm. Surfactant works in neonatal RDS but has consistently failed in adult ARDS trials because the mechanism is different. Break it down: prone positioning = the only ARDS rescue intervention with proven mortality reduction (PROSEVA trial, 16% absolute); iNO, surfactant, high-dose steroids = improve numbers but not survival; severe ARDS = P/F <150.
Question 2 of 8

A 38-year-old man with ARDS from aspiration pneumonia is intubated and ventilated on settings of FiO2 0.6, PEEP 12, tidal volume 550 mL (actual body weight 70 kg, height 5 ft 10 in, IBW 75 kg). On day 3, his peak airway pressure is 45 cmH2O and plateau pressure is 38 cmH2O. Chest X-ray shows a new right-sided pneumothorax.

Which ventilator management error most directly contributed to this complication?
AInsufficient PEEP allowing cyclic alveolar collapse
BTidal volume exceeding 6 mL/kg IBW, causing excessive alveolar distension
CFiO2 too high causing oxygen toxicity
DRespiratory rate too fast causing auto-PEEP
Correct: B

Good instinct on oxygen toxicity: high FiO2 is a real concern in ARDS. But oxygen toxicity doesn't cause pneumothorax; it causes diffuse alveolar damage over days. Pneumothorax requires a mechanical rupture, and the clue is the TV calculation. The tidal volume here is 550 mL in a patient with IBW of 75 kg: 550/75 = 7.3 mL/kg IBW. This exceeds the ARDSNET target of 6 mL/kg IBW. Think of each alveolus as a balloon: inflate it to 6 mL/kg and it stretches safely, inflate it to 7.3 mL/kg with a plateau of 38 cmH2O and you are popping balloons. More importantly, the plateau pressure is 38 cmH2O, well above the target of <30 cmH2O. This is barotrauma and volutrauma leading to pneumothorax. Volutrauma (overdistension from high volume), barotrauma (rupture from high pressure), atelectrauma (cyclic collapse from low PEEP), and biotrauma (inflammatory amplification). Oxygen toxicity does not cause pneumothorax. Auto-PEEP from high respiratory rate can cause pneumothorax but is not the primary issue here. Break it down: ARDS TV target = 6 mL/kg IBW (NOT actual weight); plateau pressure target = <30 cmH2O; exceeding either = volutrauma/barotrauma = pneumothorax risk; IBW not actual weight is the most common vent error tested.
Question 3 of 8

A 65-year-old woman presents with acute onset bilateral infiltrates and severe hypoxemia after a blood transfusion. She has a history of atrial fibrillation and is on furosemide for mild heart failure. BNP is 210 pg/mL (slightly elevated). Echocardiogram shows preserved LV ejection fraction of 60% and no wall motion abnormalities. PCWP measured via Swan-Ganz catheter is 11 mmHg.

Which finding best distinguishes this presentation as ARDS (TRALI) rather than cardiogenic pulmonary edema?
ABilateral infiltrates on chest X-ray
BMildly elevated BNP
CPCWP of 11 mmHg with normal LV function
DHistory of atrial fibrillation and furosemide use
Correct: C

Tempting to use BNP as the distinguishing test: it's cardiac, it's elevated, and she has a cardiac history. The trap is that BNP elevation in ARDS is explained by right heart strain from hypoxia, not left-sided failure. Think of the lungs as a water main that can break for two completely different reasons: too much pressure from the pump (cardiogenic, high PCWP), or a crack in the pipe wall (ARDS, capillary leak, low PCWP). Only the PCWP tells you which pipe failed. PCWP <18 mmHg combined with normal LV function on echo is the strongest objective evidence against cardiogenic pulmonary edema. In cardiogenic edema, elevated left-sided filling pressures (PCWP ≥18) drive fluid into the alveoli. Here, the PCWP is 11 and LV function is preserved, so the edema is being driven by capillary leak (ARDS/TRALI mechanism), not hydrostatic pressure. Bilateral infiltrates appear in both ARDS and cardiogenic edema. BNP can be mildly elevated in ARDS from right heart strain and does not confirm cardiogenic cause. The objective PCWP measurement is the definitive differentiator here. Break it down: PCWP <18 + normal LV = ARDS (capillary leak); PCWP ≥18 = cardiogenic; BNP can be mildly elevated in ARDS from right heart strain; the hemodynamic measurement, not the history, differentiates the two.
Question 4 of 8

A 47-year-old man is in the ICU on mechanical ventilation for ARDS from community-acquired pneumonia. His ABG on current settings shows: pH 7.28, PaCO2 56 mmHg, PaO2 68 mmHg, FiO2 0.55, PEEP 10 cmH2O. Tidal volume is 6 mL/kg IBW and plateau pressure is 26 cmH2O.

What is the P/F ratio and the most appropriate next step in management?
AP/F = 124; increase tidal volume to 10 mL/kg IBW to correct hypercapnia
BP/F = 124; add bicarbonate infusion and increase respiratory rate
CP/F = 124; maintain current tidal volume and accept permissive hypercapnia
DP/F = 68; this patient does not meet criteria for ARDS
Correct: C

Tempting to increase TV or add bicarbonate to fix the pH 7.28: it's acidotic, the CO2 is high, and fixing those numbers feels like good medicine. The trap is that ARDS lung-protective ventilation intentionally allows CO2 to rise to keep volumes safe. Think of permissive hypercapnia as deliberately running the engine a little hot to avoid blowing the transmission: accept the CO2 as long as pH stays above 7.20, because the alternative (bigger breaths) tears the lung apart. P/F ratio = 68 / 0.55 = 124 mmHg. This is moderate ARDS (P/F 100-200). The pH is 7.28 from respiratory acidosis (high PaCO2 of 56), which is acceptable permissive hypercapnia as long as pH >7.20. The tidal volume is already at 6 mL/kg IBW and plateau pressure is 26 cmH2O (below 30), so current vent settings are optimal. No change in TV is indicated. Increasing TV to 10 mL/kg IBW would be a major protocol violation. Adding bicarbonate is not standard. Choice D miscalculates P/F: use FiO2 as a decimal (0.55), not 1.0. Break it down: permissive hypercapnia = accept PaCO2 up to 50-60 mmHg as long as pH >7.20; this protects against volutrauma; never increase TV to fix CO2 in ARDS; P/F calculation always divides by FiO2 as a decimal.
Question 5 of 8

A 44-year-old man is intubated for respiratory failure one week after a severe motor vehicle accident with pulmonary contusions. Chest X-ray shows bilateral infiltrates with no effusions. Echocardiogram shows normal LV function. ABG on current ventilator settings: PaO2 75 mmHg, FiO2 0.50, PEEP 8 cmH2O.

According to the Berlin definition, what ARDS severity category applies, and why?
AMild ARDS: P/F 201 to 300 with PEEP at or above 5
BModerate ARDS: P/F 101 to 200 with PEEP at or above 5
CSevere ARDS: P/F at or below 100 with PEEP at or above 5
DDoes not meet ARDS criteria: onset more than 1 week from the known insult
Tempting to call P/F 150 severe ARDS since it sounds dangerously low, but the Berlin definition has three tiers and P/F 101-200 is moderate. Think of the Berlin severity ladder as three rungs: mild = P/F 201-300, moderate = 101-200, severe = 100 and below. P/F 150 lands squarely on the middle rung. Correct: B -- Moderate ARDS.

P/F ratio = 75 / 0.50 = 150 mmHg. Berlin severity: Mild (P/F 201 to 300), Moderate (P/F 101 to 200), Severe (P/F 100 or below). All three tiers require PEEP or CPAP at or above 5 cmH2O. This patient has P/F 150 and PEEP 8 -- moderate ARDS.

Why not D: the Berlin definition requires onset within 1 week of a known clinical insult or new/worsening respiratory symptoms. The injury was 1 week ago and he is now intubated -- the insult is the trauma, and the ARDS developed within the required window. Break it down: P/F is always PaO2 divided by FiO2 as a decimal. No exceptions.
Question 6 of 8

A 36-year-old woman with severe ARDS (P/F ratio 78) from influenza pneumonitis is on lung-protective ventilation: TV 6 mL/kg IBW, plateau pressure 26 cmH2O, PEEP 14, FiO2 0.80. She is sedated but has severe patient-ventilator dyssynchrony with breath stacking. Despite increasing propofol, dyssynchrony persists.

Which intervention is most appropriate to improve ventilator synchrony and lung protection in the first 48 hours?
AAdd cisatracurium infusion for 48 hours (neuromuscular blockade)
BSwitch to high-frequency oscillatory ventilation (HFOV)
CBegin inhaled nitric oxide to reduce pulmonary vascular resistance
DReduce PEEP to 8 to allow more spontaneous breathing effort
Tempting to switch to HFOV since it sounds like maximal ventilator support for a crashing patient with refractory dyssynchrony, but HFOV was shown to cause harm in the OSCILLATE trial and is no longer recommended. Think of neuromuscular blockade as taking the patient's hands off the steering wheel: the ventilator can deliver perfect lung-protective breaths only after the patient stops fighting the controls. Correct: A -- Neuromuscular blockade with cisatracurium.

In severe ARDS with refractory dyssynchrony, a 48-hour cisatracurium infusion eliminates patient-initiated breath stacking, reduces transpulmonary pressure swings, and may attenuate biotrauma. The ACURASYS trial showed reduced 90-day mortality with early NMB in severe ARDS (P/F below 150). The ROSE trial did not confirm mortality benefit but confirmed NMB is safe and effective for dyssynchrony control.

Why not the others: HFOV (choice B) was shown to cause harm in the OSCILLATE trial and is no longer recommended. iNO (C) improves oxygenation transiently but has no mortality benefit. Reducing PEEP (D) would worsen atelectrauma in severe ARDS. Break it down: NMB = eliminate dyssynchrony, protect the lung from the patient herself.
Question 7 of 8

A 58-year-old man with moderate ARDS (P/F 155) from gram-negative sepsis has been mechanically ventilated for 3 days. His hemodynamics are stable: BP 122/74, HR 82, CVP 9, urine output 45 mL/hr. He has received 4 L of IV fluid since admission. The team is debating fluid management strategy going forward.

Which fluid management approach has the best evidence for improving pulmonary outcomes in this patient?
AConservative strategy: target net zero to negative fluid balance using diuretics as needed
BLiberal strategy: maintain CVP 12 to 15 to optimize cardiac preload and DO2
CAggressive diuresis targeting CVP below 4 regardless of urine output
DNo intervention: fluid balance should be guided by spontaneous diuresis only
Tempting to maintain a liberal fluid strategy with high CVP to optimize cardiac output, since ICU training emphasizes perfusion, but in ARDS the edema is driven by capillary leak, not preload deficit. Think of ARDS lungs as a basement with a cracked wall: pouring more water into the building raises the hydrostatic pressure and accelerates seepage through the cracks. Conservative strategy lowers the water pressure and lets the cracks dry. Correct: A -- Conservative fluid strategy.

The FACTT trial (NEJM 2006) compared conservative versus liberal fluid management in ARDS. Conservative strategy resulted in more ventilator-free days, more ICU-free days, and improved oxygenation -- without increasing renal failure or organ dysfunction in hemodynamically stable patients. Mortality was not significantly different, but lung function was measurably better.

The logic: ARDS edema is driven by capillary leak, not hydrostatic pressure. Excess fluid fills already-leaky alveoli and worsens gas exchange. Conservative fluid management reduces the hydrostatic gradient and helps clear edema. Break it down: dry lungs breathe better. When hemodynamics allow it, pull fluid out.
Question 8 of 8

A 29-year-old woman with severe ARDS (P/F 62) from influenza pneumonitis has been proned for 18 hours/day for 3 days and is on cisatracurium. PEEP is 18 cmH2O and FiO2 is 0.90. pH is 7.17 from respiratory acidosis (PaCO2 78 mmHg) despite optimal ventilator settings. Plateau pressure is 29 cmH2O.

She has failed all conventional rescue measures. What is the most appropriate next intervention?
AIncrease tidal volume to 9 mL/kg IBW to improve CO2 clearance
BAdd high-dose methylprednisolone (2 mg/kg/day)
CInitiate veno-venous ECMO as rescue therapy
DSwitch to pressure-regulated volume control mode
Tempting to increase the tidal volume to fix the pH 7.17 and rising CO2 since respiratory acidosis is the immediate threat, but increasing TV in ARDS is the wrong direction at any stage , the ventilator is already at its safe limit and more volume causes volutrauma. Think of VV-ECMO as an external blood oxygenation bypass when the lung itself is removed from the equation: the machine does the gas exchange while the lung rests at the lowest tolerable settings. Correct: C -- Veno-venous ECMO.

VV-ECMO is the rescue therapy for severe ARDS refractory to all conventional measures: optimal lung-protective ventilation, prone positioning, and neuromuscular blockade. Indications include P/F below 80 despite FiO2 at 1.0, or uncompensated respiratory acidosis (pH below 7.20) on optimal vent settings. The EOLIA trial showed a trend toward mortality benefit; VV-ECMO is now an accepted rescue measure at experienced centers.

Why not the others: Increasing TV to 9 mL/kg IBW (A) violates the core ARDS protocol and would increase volutrauma -- this is the wrong direction. High-dose steroids (B) are not indicated in early severe ARDS and some data suggest harm in the first week. Changing ventilator mode (D) to PRVC does not alter the underlying problem and provides no rescue when mechanics are already optimal. Break it down: when the lungs fail despite everything, bypass them.
0/8
quiz complete
Board-Style Walkthrough

Board-Style Walkthrough

Original board-style vignettes. Shuffled, never-repeat, full explanations for every choice.